Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Regulatory reform proposal

Executive Summary

Regulatory reform proposal: White House director of regulatory risk analysis would coordinate activities between FDA and six other federal agencies, under a proposal released March 20 by the Harvard Group on Risk Management Reform. Chaired by former Bush Administration Counsel C. Boyden Gray, the group also recommends increased local authorities, particularly "where the costs and benefits of risk management are incurred by citizens within a specific state or locality." Congress should also allow the feds flexibility to approve risk-management plans submitted by regulatees that would result in greater reduction of risk than would result from compliance with existing law...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS025958

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel